Dexcom (DXCM) Inventory Average (2011 - 2026)

Dexcom (DXCM) has 16 years of Inventory Average data on file, last reported at $661.4 million in Q1 2026.

• Quarterly Inventory Average rose 22.38% year-over-year to $661.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $661.4 million (up 22.38% YoY) and the FY2025 annual result came in at $585.8 million, up 6.31% from the prior year.
• Inventory Average advanced to $661.4 million in Q1 2026 per DXCM's latest filing, from $616.6 million in the prior quarter.
• Across five years, Inventory Average topped out at $661.4 million in Q1 2026 and bottomed at $308.8 million in Q4 2022.
• The 5-year median for Inventory Average is $540.4 million (2025), against an average of $488.3 million.
• The widest annual swing landed in 2022, when Inventory Average decreased 12.83%; it then soared 71.31% in 2023.
• Tracing DXCM's Inventory Average over 5 years: stood at $308.8 million in 2022, then soared by 71.31% to $529.1 million in 2023, then rose by 6.68% to $564.4 million in 2024, then grew by 9.24% to $616.6 million in 2025, then climbed by 7.26% to $661.4 million in 2026.
• Per Business Quant, the three latest DXCM Inventory Average figures stand at $661.4 million (Q1 2026), $616.6 million (Q4 2025), and $587.4 million (Q3 2025).

Peer Comparison